India, July 16 -- Today's top gainers in the biotech space include CareDx, which rallied after Medicare finalized its Local Coverage Determination process for molecular testing of solid organ allograft rejection; AtaiBeckley, after agreeing to be acquired by Eli Lilly; and Abbott, after reporting second-quarter results and providing an upbeat outlook, among others.
Read on.
CDNA Soars to New High
CareDx Inc. (CDNA) was the top gainer on Thursday, with shares soaring more than 35%, following finalization of the Medicare Local Coverage Determination (LCD) process related to molecular testing for solid organ allograft rejection.
The finalized policy confirms Medicare coverage for the company's transplant surveillance portfolio, including A...